# Drug Interaction Study With Dabigatran Etexilate and Dronedarone in Healthy Subjects

> **NCT01306162** · PHASE1 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 36 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Dabigatran etexilate plus dronedarone
- **DRUG:** Dabigatran etexilate
- **DRUG:** Dabigatran etexilate plus dronedarone
- **DRUG:** Dabigatran etexilate plus dronedarone
- **DRUG:** Dabigatran etexilate plus dronedarone

## Key facts

- **NCT ID:** NCT01306162
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-02
- **Primary completion:** 2011-05
- **Final completion:** —
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2014-06-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01306162

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01306162, "Drug Interaction Study With Dabigatran Etexilate and Dronedarone in Healthy Subjects". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01306162. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*